Thursday, January 11, 2018

Pharma Reviews: Policy anomalies mar Indian API firms, help China rule the roost

If proper and regular inspections are conducted, many Chinese bulk drug exporters will be out of the game, industry sources say. The argument holds water as recently India's drug regulator Drug Controller General of India (DCGI) has banned the import of ingredients of drugs from six major Chinese ...
Read more: Policy anomalies mar Indian API firms, help China rule the roost